Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00490
Species: Homo sapiens
Position : chr15:45650000-45651000
Year: 2023
Title: Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modifications
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: pancreatic ductal adenocarcinoma
PMID:  37370109
MONDO: MONDO:0005147
Tissue: Pancreas
Tissue Ontology ID: UBERON:0001264
Cell Source: PANC-1-IN
CVCL ID:
Cell Type: pancreatic ductal adenocarcinoma cell
Cell Ontology ID: CL:0000066
Experiment Type: Enhancer activity assay, Chromatin interaction assay, Functional perturbation assay
High Throughput Method: Hi-C, ChIP-seq
Low Throughput Method: CRISPRi (dCas9-KRAB), ChIP-RT-qPCR, 3C-RT-qPCR, RT-RT-qPCR, Western blot
About Target Gene
Target gene : GATM
About TF
TF name :
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 2 found
Enhancer ID Position Tissue Cell Disease
E_00491 chr15:45650000-45651000 Pancreas pancreatic ductal adenocarcinoma cell pancreatic ductal adenocarcinoma
E_00492 chr15:45650000-45651000 Pancreas pancreatic ductal adenocarcinoma cell pancreatic ductal adenocarcinoma
Expression of Target Genes for the Enhancer